Liver Cirrhosis, Experimental
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Experimental Model of Disease
|
870
|
|
0.300 |
None |
1.000 |
2 |
|
2006 |
2014 |
Thyroid Diseases
|
group |
Endocrine System Diseases
|
Disease or Syndrome
|
230
|
26
|
0.300 |
None |
1.000 |
1 |
|
2007 |
2007 |
Inborn Errors of Metabolism
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome; Congenital Abnormality
|
119
|
3
|
0.300 |
None |
1.000 |
1 |
|
2007 |
2007 |
Hyperthyroxinemia
|
disease |
Endocrine System Diseases
|
Disease or Syndrome
|
5
|
1
|
0.300 |
None |
1.000 |
1 |
|
1988 |
1988 |
Mammary Neoplasms, Experimental
|
phenotype |
Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
218
|
|
0.200 |
None |
1.000 |
1 |
|
2001 |
2001 |
Thyroxine measurement
|
phenotype |
|
Laboratory Procedure
|
24
|
42
|
0.100 |
None |
1.000 |
2 |
1
|
2013 |
2015 |
Multiple Myeloma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases; Cardiovascular Diseases
|
Neoplastic Process
|
1740
|
865
|
0.100 |
None |
1.000 |
1 |
1
|
2013 |
2013 |
Thyroid stimulating hormone measurement
|
phenotype |
|
Laboratory Procedure
|
42
|
83
|
0.100 |
None |
1.000 |
1 |
1
|
2013 |
2013 |
Hormone measurement
|
group |
|
Laboratory Procedure
|
51
|
134
|
0.100 |
None |
1.000 |
1 |
1
|
2013 |
2013 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.030 |
None |
1.000 |
3 |
|
2005 |
2011 |
Depressive disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
1719
|
297
|
0.030 |
None |
1.000 |
3 |
|
2016 |
2017 |
Mental Depression
|
disease |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
1478
|
271
|
0.030 |
None |
1.000 |
3 |
|
2016 |
2017 |
Euthyroid Sick Syndromes
|
disease |
Endocrine System Diseases
|
Disease or Syndrome
|
9
|
1
|
0.030 |
None |
1.000 |
3 |
|
2015 |
2018 |
Depressed mood
|
phenotype |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
1461
|
269
|
0.030 |
None |
1.000 |
3 |
|
2016 |
2017 |
Papillary thyroid carcinoma
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
1348
|
204
|
0.030 |
None |
1.000 |
3 |
|
2005 |
2015 |
Endometrial Stromal Sarcoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
75
|
1
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2018 |
Renal carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
665
|
21
|
0.020 |
None |
1.000 |
2 |
|
2009 |
2017 |
Malignant neoplasm of kidney
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
664
|
22
|
0.020 |
None |
1.000 |
2 |
|
2009 |
2017 |
Recurrent depressive disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
29
|
9
|
0.020 |
None |
0.500 |
2 |
|
2016 |
2016 |
Laryngeal Squamous Cell Carcinoma
|
disease |
Neoplasms; Respiratory Tract Diseases; Otorhinolaryngologic Diseases
|
Neoplastic Process
|
504
|
30
|
0.020 |
None |
1.000 |
2 |
|
2019 |
2019 |
Conventional (Clear Cell) Renal Cell Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
2346
|
222
|
0.020 |
None |
1.000 |
2 |
|
2010 |
2011 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.020 |
None |
1.000 |
2 |
|
2009 |
2017 |
Hyperthyroidism
|
disease |
Endocrine System Diseases
|
Disease or Syndrome
|
279
|
27
|
0.020 |
None |
1.000 |
2 |
|
2019 |
2019 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.020 |
None |
1.000 |
2 |
|
2009 |
2017 |
Kidney Failure, Chronic
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
827
|
425
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2018 |